The Current State Of FDA-Approved AI-Enabled Medical Devices.
Summary
This article provides an overview of the current landscape of AI-enabled medical devices that have received FDA approval, highlighting trends and regulatory progress in healthcare technology.
View Cached Full Text
Cached at: 05/11/26, 04:34 PM
Similar Articles
FDA Shortens Clinical Trial Timelines for Drugs and Medical Devices with AI
The FDA launches a pilot program using Causal AI to shorten clinical trial timelines for drugs and medical devices, potentially reducing trial duration by 20-40% and speeding regulatory approval.
Towards Next-Generation Healthcare: A Survey of Medical Embodied AI for Perception, Decision-Making, and Action
This paper systematically surveys the core components of medical embodied AI, emphasizing the coordinated integration of perception, decision-making, and action in clinical environments, and reviews representative applications, datasets, and future research directions.
Trends in AI and Human-AI Interaction in Clinical Trials -- A Hybrid Human-AI Exploration
This paper analyzes temporal and geographical trends in AI terminology in clinical trials from clinicaltrials.gov, using a hybrid human-AI approach with GPT-5.5. It finds increasing AI-related trials, with China and the US leading, and discusses the viability of hybrid screening for human-AI interaction classification.
AI is accelerating drug development
AI is transforming U.S. pharmaceutical R&D by accelerating drug discovery, preclinical testing, clinical trials, and regulatory review, with early evidence suggesting it could cut development times by roughly half and reduce costs.
Artificial Intelligence Index Report 2026
The ninth edition of the AI Index report analyzes the gap between AI advancement and societal preparedness, featuring new assessments of reasoning, safety, economic value, labor effects, and dedicated chapters on AI in science and medicine.